Common Blood Pressure Drug Class Tied to 33% Higher Kidney Risk in Type 2 Diabetics, Study Finds Researchers examining health records of 31,031 adults with Type 2 diabetes found that use of dihydropyridine calcium-channel blockers (DCCBs) was associated with a 33% higher risk of major adverse kidney events, according to findings presented Aug. 18, 2026, at the 63rd ERA Congress. The findings, released by the European Renal Association, apply to patients already receiving RAS inhibitors and SGLT2 inhibitors, the report stated. The medications, known as DCCBs, lower blood pressure by relaxing blood vessels and are often prescribed as second-line treatments…
Newswire
Switching to low-plastic diet and personal care products linked to rapid drop in urinary phthalates, bisphenol levels, trial finds Researchers…
Sources include: MedicalNewsToday.com Healthline.com Health.ClevelandClinic.org OmMushrooms.com HealthRangerStore.com 1 HealthRangerStore.com 2 BrightU.ai Brighteon.com Read full article here Click on this link…
Purslane Extract Tied to Improved Mood and Reduced Liver Stiffness in Trials, Researchers Say Purslane, a weed commonly found in…
So much has been written about how to eat for a healthy heart that most of us know the basics…
“The Grid Crisis” argues that the U.S. power grid’s vulnerability is a man-made catastrophe, not an accident, resulting from intentional…
Trending
Trending Videos
Trending Videos
Features
The Latest
Stubborn belly fat can be incredibly frustrating. It changes how your clothes fit. It can make you feel self-conscious. And…
Welcome to My World of Self-Imposed Challenges When it comes to genuine preparedness, an important mental game you can play…
X Post Lists Responses to Pro-Israel Arguments, Drawing Thousands of Interactions A post on X by the account @mladner30, published…
(Ken Silva, Headline USA) When Anthony Fauci was leading the federal government’s response to the COVID-19 pandemic, he frequently touted…
“The Long Winter: A Mother’s Promise on the Oregon Trail” centers on a mother’s poignant question to Dr. Andrew Wakefield…
(Headline USA) U.S. health officials on Monday proposed a rule change that would require food manufacturers to notify regulators before…